Catalyst Wire Dossier Catalyst Wire Dossier

Telaprevir (TMC435)

telaprevir · Vertex Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Telaprevir (TMC435), covering 2013-04-09 to 2013-04-09. Get the full timeline:

Most recent: Clinical Trial Update: TMC435-TiDP16-C112 - Interaction Trial With Antidepressants [Phase 1]

See pricing